摘要
【目的】比较经尿道等离子前列腺剜除术(PKEP)、经尿道双极等离子前列腺切除术(PKRP)和开放耻骨上前列腺摘除术(OP)治疗大体积前列腺增生症的疗效和并发症。【方法】选择2007年1月至2009年6月入本院接受手术治疗的大体积良性前列腺增生(BPH)患者60例,随机分为三组,分别接受PKRP(n=20)、PKEP(n=20)和OP(n=20)治疗。观察并比较三组手术时间、切除腺体重量、出血量、术后膀胱持续冲洗时间、术后留置导尿时间、术后住院天数以及尿失禁等并发症。术后均随访3年。分别于术后1、6、12、24、36个月行IPSS及QOL评分、最大尿流率(Qmax)及残余尿量测定。【结果】OP组手术时间最短、切除组织最多,但出血量最多、术后尿管留置时间和术后住院时间最长(与PKEP组和PKRP组相比P均〈0.05)。PKEP组出血量最少、尿管留置时间和术后住院时间最短(与OP组和PKRP组相比P均〈0.05)。随访结果表明,PKEP组的远期疗效与OP组相当,均优于PKRP组(P〈0.05)。【结论】PKRP、PKEP和OP均能显著改善大体积前列腺增生的排尿症状。但PKEP创伤小、安全高、远期疗效好,是治疗大体积前列腺增生的优先选择。
[Objective] To compare the efficacy and complications of plasmakinetic resection of the prostate (PKRP), plasmakinetic enucleation of the prostate (PKEP) and open prostatectomy(OP) for the treatment of large volume benign prostatic hyperplasia(BPH). [Methods]From January 2007 to June 2009, 60 patients with large vol- ume BPH in our hospital were randomized to PKRP group( n = 20), PKEP group( n : 20) and OP group( n = 20). Operation time, resected tissue weight, blood loss, postoperative bladder irrigation time, postoperative catheterization time, postoperative hospital stay and complications such as urinary incontinence were observed and compared among 3 groups. All patients were followed up for 3 years. IPSS, QOL scores, Qmax and residual urine were determined at 1, 6, 12, 24, and 36 months postoperatively, respectively. [Results]Compared with PKRP group and PKEP group, shorter operation time, more resected tissue weight, more blood loss, longer catherization time and postoperative hos- pital stay were observed in OP group(all P d0.05). Compared with OP group and PKRP group, less blood loss, shorter catheterization time and postoperative hospital stay were observed in PKEP group(all P d0.05). The 3-year follow-up data showed that the long-term efficacy of PKEP was equivalent to OP and superior to PKRP. [Conclu- sion]PKRP, PKEP and OP can all improve the micturition symptoms of large-volume BPH. PKEP has less invasion, higher security and better long-term efficacy, so it should be considered as the priority of choice for the treatment of large-volume BPH.
出处
《医学临床研究》
CAS
2013年第3期433-436,共4页
Journal of Clinical Research